| 发明名称 |
CONTROLLED-RELEASE DRUG FORMULATION |
| 摘要 |
The present invention provides a controlled-release solid preparation containing pioglitazone or a salt thereof as an active ingredient, and having superior sustainability.;A controlled-release solid preparation containing pioglitazone or a salt thereof as an active ingredient, which is composed of an immediate-release part and a sustained-release part in combination. |
| 申请公布号 |
US2016113913(A1) |
申请公布日期 |
2016.04.28 |
| 申请号 |
US201414784996 |
申请日期 |
2014.04.18 |
| 申请人 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED |
发明人 |
Murakawa Yusuke;Tsutsumi Shunichiro;Takenaka Kaoru;Inoo Kanako |
| 分类号 |
A61K31/4439;A61K9/48;A61K9/16;A61K9/28;A61K9/24 |
主分类号 |
A61K31/4439 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A controlled-release solid preparation comprising pioglitazone or a salt thereof in an amount of 0.1-8 mg as pioglitazone per preparation unit, which is composed of an immediate-release part, and a sustained-release part in combination. |
| 地址 |
Osaka JP |
